Track topics on Twitter Track topics that are important to you
MISSIONActivBiotics is focused on the development and commercialization of antibacterials for the treatment of acute and chronic disease.
ActivBiotics is developing rifalazil - a potent broad spectrum antibiotic that targets and inhibits the transcriptional machinery of bacteria. Previously studied in Phase I and IIA clinical trials, rifalazil is currently being planned for additional Phase II trials in several indications. In addition, ActivBiotics is owns a proprietary library of structurally related new chemical entities (NCEs).
2 Oliver Street, 3rd Floor
United States of America
Phone: (617) 423 9995
Fax: (617) 423 9997
MISSIONActivBiotics is focused on the development and commercialization of antibacterials for the treatment of acute and chronic disease.PRODUCT PORTFOLIOActivBiotics is developing rifalazil - a poten...
We have published hundreds of ActivBiotics news stories on BioPortfolio along with dozens of ActivBiotics Clinical Trials and PubMed Articles about ActivBiotics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ActivBiotics Companies in our database. You can also find out about relevant ActivBiotics Drugs and Medications on this site too.
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...